HomeRKV • CVE
add
Rakovina Therapeutics Inc
Previous close
$0.23
Year range
$0.23 - $2.30
Market cap
4.86M CAD
Avg Volume
26.82K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.83M | 273.76% |
Net income | -2.92M | -255.41% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.69M | -332.55% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.88M | 35.81% |
Total assets | 6.55M | 5.25% |
Total liabilities | 3.34M | 37.92% |
Total equity | 3.22M | — |
Shares outstanding | 21.15M | — |
Price to book | 1.53 | — |
Return on assets | -124.66% | — |
Return on capital | -148.32% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.92M | -255.41% |
Cash from operations | -3.03M | -588.62% |
Cash from investing | — | — |
Cash from financing | 4.84M | 193.24% |
Net change in cash | 1.81M | 49.45% |
Free cash flow | -1.98M | -1,037.55% |
About
Founded
2019
Headquarters
Website
